Alimera Sciences
ALIM
ALIM was delisted on the 13th of September, 2024.
41 hedge funds and large institutions have $39M invested in Alimera Sciences in 2017 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 11 increasing their positions, 6 reducing their positions, and 5 closing their positions.
576% more capital inflows, than outflows
Capital inflows: $5.45M | Capital outflows: $807K
83% more repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 6
80% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 5
8% more funds holding
Funds holding: 38 → 41 (+3)
2.25% more ownership
Funds ownership: 39.58% → 41.83% (+2.3%)
46% less call options, than puts
Call options by funds: $15K | Put options by funds: $28K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Deerfield Management
New York
|
+$1.83M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$668K |
| 3 |
Renaissance Technologies
New York
|
+$572K |
| 4 |
Armistice Capital
New York
|
+$519K |
| 5 |
Avoro Capital Advisors
New York
|
+$499K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Parkwood LLC
Cleveland,
Ohio
|
-$317K |
| 2 |
Goldman Sachs
New York
|
-$264K |
| 3 |
ARTA
A.R.T. Advisors
New York
|
-$115K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$31.9K |
| 5 |
Weiss Multi-Strategy Advisers
New York
|
-$5.71K |
ALIM Hedge Fund Activity: Q3 2017 in Review
41 of the 4,023 institutional investors tracked by Wall St. Rank reported a position in Alimera Sciences (ALIM) for Q3 2017, worth a combined $39M — up 9.2% from $35.7M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new ALIM positions and 5 closed out — a net gain of 4 holders — while 11 added to existing stakes and 6 trimmed.
The largest buyer was Deerfield Management, adding an estimated $1.83M. The largest seller was Parkwood LLC, exiting entirely with an estimated $317K sold.
- 41 institutional investors held Alimera Sciences (ALIM) as of Q3 2017, up from 38 in Q2 2017.
- Funds reported $39M of Alimera Sciences stock for Q3 2017, up 9.2% quarter-over-quarter.
- 9 funds opened new Alimera Sciences positions in Q3 2017 and 5 closed out, a net change of +4 holders.
- The largest Alimera Sciences buyer in Q3 2017 was Deerfield Management, an estimated $1.83M added.
- The largest Alimera Sciences seller in Q3 2017 was Parkwood LLC, an estimated $317K sold.
Based on aggregated 13F filings for Q3 2017.